Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News Archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 385 results
August 2020
-
Guidance system lights a path for drug discovery
Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.
-
Building collaborations to fight a pandemic
Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.
-
Ensuring medicine supply to patients during COVID-19
Read how two sites within the Novartis Technical Operations (NTO) network ensured business continuity at scale and speed in the midst of the COVID-19 pandemic.
July 2020
-
Collaborating to explore new gene regulation therapies
Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.
-
Breaking a vicious cycle of inflammation
Novartis researchers aim to quash inflammation to treat chronic disease.
-
Helping clinical trial patients during a lockdown
Yan Zhao talks about how her team in China responded to an emerging public health crisis.
-
Cancer didn’t stop for COVID-19
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
May 2020
-
Moving from speculation to science during a pandemic
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
-
It takes an R&D village to fight a pandemic
Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Pagination
- ‹ Previous page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- …
- 33
- › Next page